RECRUITING

Magnetic Resonance Imaging of Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.

Official Title

Magnetic Resonance Imaging of Breast Cancer

Quick Facts

Study Start:1995-04-01
Study Completion:2027-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01035112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Male by birth
  2. * Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to
  3. * MR contraindications including
  4. * Pacemakers
  5. * Metallic implants
  6. * Severe claustrophobia
  7. * Aneurysm clips
  8. * Pregnancy
  9. * Current lactation
  10. * Other conditions precluding proximity to a strong magnetic field.
  11. * Received an enhanced MR procedure within 48 hours,
  12. * Iodinated contrast within six hours,
  13. * Known sensitivity to MR contrast agents,
  14. * Not likely to complete the study in full or
  15. * Other clinical reason which would preclude participation in the protocol.

Contacts and Locations

Study Contact

Jocelyn Steffan
CONTACT
650-725-1812
jsteffen@stanford.edu

Principal Investigator

Bruce L Daniel
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University School of Medicine
Stanford, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Bruce L Daniel, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1995-04-01
Study Completion Date2027-05

Study Record Updates

Study Start Date1995-04-01
Study Completion Date2027-05

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer
  • Breast Cancer Non-invasive Breast Cancer